BEUDAMED
    83 results · 17ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 3 ×

    Immunohistochemistry Assay, Antibody, Claudin 18

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA CLDN18 (43-14A) RxDx Assay

    Immunohistochemistry Assay, Antibody, Claudin 18

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA CLDN18 (43-14A) RxDx Assay

    Immunohistochemistry Assay, Antibody, Claudin 18

    FDA classification
    FDA Class 3 ·Immunohistochemistry Assay, Antibody, Claudin 18

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT ENDOPROSTHESIS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent™ Venous Endoprosthesis with Unistep Plus™ Delivery System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent (Venous) Endoprosthesis With Unistep Plus Delivery System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (TIPS, ILIAC, VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Sensor, Glucose, Implanted, Non-Adjunctive Use

    FDA Pre-Market Approval
    FDA Class 3 ·Eversense Continuous Glucose Monitoring System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM (VENOUS)

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT ENDOPROSTHESIS

    Sensor, Glucose, Implanted, Non-Adjunctive Use

    FDA Pre-Market Approval
    FDA Class 3 ·Eversense Continuous Glucose Monitoring System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT SYSTEM (10 MM VENOUS ENDOPROSTHESIS) AND UNISTEP PLUS DELIVERY SYSTEM (12 MM VENOUS ENDOPROSTHESIS)

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (VENOUS) ENDOPROSTHESIS

    Sensor, Glucose, Implanted, Non-Adjunctive Use

    FDA Pre-Market Approval
    FDA Class 3 ·Eversense® E3 Continuous Glucose Monitoring System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent (Venous) Endoprosthesis With Unistep Plus Delivery System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

    Sensor, Glucose, Implanted, Non-Adjunctive Use

    FDA Pre-Market Approval
    FDA Class 3 ·Eversense E3 Continuous Glucose Monitoring System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (ILIAC, TIPS, VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Sensor, Glucose, Implanted, Non-Adjunctive Use

    FDA Pre-Market Approval
    FDA Class 3 ·Eversense E3 Continuous Glucose Monitoring System (CGM System) - Entire System, Eversense E3 Sensor, Eversense E3 Insert